Financial Summary (All financials)
| In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| Revenues | 389.7 | 274.2 | 315.9 | 333.4 | 158.0 | 159.3 | 167.4 | 289.2 |
| Revenue growth | 42.1% | -13.2% | -5.2% | 111.0% | -0.8% | -4.8% | -42.1% | 177.7% |
| Cost of goods sold | 42.1 | 45.0 | 44.0 | 42.7 | 41.6 | 42.8 | 43.7 | 31.4 |
| Gross profit | 347.6 | 229.3 | 271.9 | 290.7 | 116.4 | 116.5 | 123.7 | 257.8 |
| Gross margin | 89.2% | 83.6% | 86.1% | 87.2% | 73.6% | 73.1% | 73.9% | 89.1% |
| Research and development | | | | | | | | |
| General and administrative | 32.1 | 30.2 | 33.9 | 23.4 | 24.4 | 26.2 | 21.7 | 29.8 |
| EBIT | 198.4 | 99.7 | 116.1 | 161.1 | 2.1 | 3.8 | 14.0 | 159.5 |
| EBIT margin | 50.9% | 36.3% | 36.7% | 48.3% | 1.3% | 2.4% | 8.4% | 55.2% |
| Pre-tax income | 172.4 | 71.9 | 92.6 | 111.8 | -50.9 | -20.4 | -1.4 | 129.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 172.4 | 71.9 | 92.6 | 111.8 | -50.9 | -20.4 | -1.4 | 129.7 |
| Net margin | 44.2% | 26.2% | 29.3% | 33.5% | -32.2% | -12.8% | -0.9% | 44.8% |
| |
| Diluted EPS | $4.29 | $1.78 | $1.86 | $2.07 | ($0.93) | ($0.38) | ($0.03) | $2.29 |
| Shares outstanding (diluted) | 40.2 | 40.4 | 49.8 | 54.1 | 54.5 | 54.0 | 54.1 | 56.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|